Antivirals Market Report

1. Global Antivirals Executive Summary

• 1.1 Introduction

• 1.2 Market Panorama, 2022

2 Coronavirus Impact

• 2.1 Antivirals Outlook to 2028- Original Forecasts

• 2.2 Antivirals Outlook to 2028- COVID-19 Affected Forecasts

• 2.3 Impact on Industry

3 Strategic Analytics to Boost Productivity and Profitability

• 3.1 Potential Market Drivers and Opportunities

• 3.2 New Challenges and Strategies

• 3.3 Short Term and Long Term Antivirals Market Trends

4 Key Inferences

5 Market Overview

• 5.1 Current Market Scenario

• 5.2 Porter's Five Forces Analysis

• 5.2.1 Bargaining Power of Suppliers

• 5.2.2 Bargaining Power of Consumers

• 5.2.3 Threat of New Entrants

• 5.2.4 Threat of Substitute Product and Services

• 5.2.5 Competitive Rivalry within the Industry

6 Global Antivirals Market- Recent Developments

• 6.1 Antivirals Market News and Developments

• 6.2 Antivirals Market Deals Landscape

7 Antivirals Raw Materials and Cost Structure Analysis

• 7.1 Antivirals Key Raw Materials

• 7.2 Antivirals Price Trend of Key Raw Materials

• 7.3 Antivirals Key Suppliers of Raw Materials

• 7.4 Antivirals Market Concentration Rate of Raw Materials

• 7.5 Antivirals Cost Structure Analysis

• 7.5.1 Antivirals Raw Materials Analysis

• 7.5.2 Antivirals Labor Cost Analysis

• 7.5.3 Antivirals Manufacturing Expenses Analysis

8 Global Antivirals Import and Export Analysis (Top 10 Countries)

• 8.1 Global Antivirals Import by Region (Top 10 Countries) (2017-2028)

• 8.2 Global Antivirals Export by Region (Top 10 Countries) (2017-2028)

9 Global Antivirals Market Outlook by Types and Applications to 2022

• 9.1 Global Antivirals Consumption and Growth Rate by Type (2017-2022)

• 9.1.1 Global Generic Consumption and Growth Rate (2017-2022)

• 9.1.2 Global Branded Consumption and Growth Rate (2017-2022)

• 9.2 Global Antivirals Consumption and Growth Rate by Application (2017-2022)

• 9.2.1 Global Application I Consumption and Growth Rate (2017-2022)

• 9.2.2 Global HIV Consumption and Growth Rate (2017-2022)

• 9.2.3 Global Hepatitis Consumption and Growth Rate (2017-2022)

• 9.2.4 Global HSV Consumption and Growth Rate (2017-2022)

• 9.2.5 Global Influenza Consumption and Growth Rate (2017-2022)

10 Region and Country-wise Antivirals Market Analysis and Outlook till 2022

• 10.1 Global Antivirals Consumption (2017-2022)

• 10.2 North America Consumption Analysis

• 10.2.1 United States Antivirals Consumption (2017-2022)

• 10.2.2 Canada Antivirals Consumption (2017-2022)

• 10.2.3 Mexico Antivirals Consumption (2017-2022)

• 10.3 Europe Consumption Analysis

• 10.3.1 Germany Antivirals Consumption (2017-2022)

• 10.3.2 UK Antivirals Consumption (2017-2022)

• 10.3.3 Spain Antivirals Consumption (2017-2022)

• 10.3.4 Belgium Antivirals Consumption (2017-2022)

• 10.3.5 France Antivirals Consumption (2017-2022)

• 10.3.6 Italy Antivirals Consumption (2017-2022)

• 10.3.7 Denmark Antivirals Consumption (2017-2022)

• 10.3.8 Finland Antivirals Consumption (2017-2022)

• 10.3.9 Norway Antivirals Consumption (2017-2022)

• 10.3.10 Sweden Antivirals Consumption (2017-2022)

• 10.3.11 Poland Antivirals Consumption (2017-2022)

• 10.3.12 Russia Antivirals Consumption (2017-2022)

• 10.3.13 Turkey Antivirals Consumption (2017-2022)

• 10.4 APAC Consumption Analysis

• 10.4.1 China Antivirals Consumption (2017-2022)

• 10.4.2 Japan Antivirals Consumption (2017-2022)

• 10.4.3 India Antivirals Consumption (2017-2022)

• 10.4.4 South Korea Antivirals Consumption (2017-2022)

• 10.4.5 Pakistan Antivirals Consumption (2017-2022)

• 10.4.6 Bangladesh Antivirals Consumption (2017-2022)

• 10.4.7 Indonesia Antivirals Consumption (2017-2022)

• 10.4.8 Thailand Antivirals Consumption (2017-2022)

• 10.4.9 Singapore Antivirals Consumption (2017-2022)

• 10.4.10 Malaysia Antivirals Consumption (2017-2022)

• 10.4.11 Philippines Antivirals Consumption (2017-2022)

• 10.4.12 Vietnam Antivirals Consumption (2017-2022)

• 10.5 South America Consumption Analysis

• 10.5.1 Brazil Antivirals Consumption (2017-2022)

• 10.5.2 Colombia Antivirals Consumption (2017-2022)

• 10.5.3 Chile Antivirals Consumption (2017-2022)

• 10.5.4 Argentina Antivirals Consumption (2017-2022)

• 10.5.5 Venezuela Antivirals Consumption (2017-2022)

• 10.5.6 Peru Antivirals Consumption (2017-2022)

• 10.5.7 Puerto Rico Antivirals Consumption (2017-2022)

• 10.5.8 Ecuador Antivirals Consumption (2017-2022)

• 10.6 GCC Consumption Analysis

• 10.6.1 Bahrain Antivirals Consumption (2017-2022)

• 10.6.2 Kuwait Antivirals Consumption (2017-2022)

• 10.6.3 Oman Antivirals Consumption (2017-2022)

• 10.6.4 Qatar Antivirals Consumption (2017-2022)

• 10.6.5 Saudi Arabia Antivirals Consumption (2017-2022)

• 10.6.6 United Arab Emirates Antivirals Consumption (2017-2022)

• 10.7 Africa Consumption Analysis

• 10.7.1 Nigeria Antivirals Consumption (2017-2022)

• 10.7.2 South Africa Antivirals Consumption (2017-2022)

• 10.7.3 Egypt Antivirals Consumption (2017-2022)

• 10.7.4 Algeria Antivirals Consumption (2017-2022)

• 10.8 Oceania Consumption Analysis

• 10.8.1 Australia Antivirals Consumption (2017-2022)

• 10.8.2 New Zealand Antivirals Consumption (2017-2022)

11 Global Antivirals Competitive Analysis

• 11.1 GSK

• 11.1.1 GSK Company Details

• 11.1.2 GSK Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.1.3 GSK Antivirals Main Business and Markets Served

• 11.1.4 GSK Antivirals Product Portfolio

• 11.1.5 Recent Research and Development Strategies

• 11.2 Aurobindo Pharma

• 11.2.1 Aurobindo Pharma Company Details

• 11.2.2 Aurobindo Pharma Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.2.3 Aurobindo Pharma Antivirals Main Business and Markets Served

• 11.2.4 Aurobindo Pharma Antivirals Product Portfolio

• 11.2.5 Recent Research and Development Strategies

• 11.3 Mylan

• 11.3.1 Mylan Company Details

• 11.3.2 Mylan Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.3.3 Mylan Antivirals Main Business and Markets Served

• 11.3.4 Mylan Antivirals Product Portfolio

• 11.3.5 Recent Research and Development Strategies

• 11.4 AbbVie

• 11.4.1 AbbVie Company Details

• 11.4.2 AbbVie Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.4.3 AbbVie Antivirals Main Business and Markets Served

• 11.4.4 AbbVie Antivirals Product Portfolio

• 11.4.5 Recent Research and Development Strategies

• 11.5 F Hoffmann-La Roche

• 11.5.1 F Hoffmann-La Roche Company Details

• 11.5.2 F Hoffmann-La Roche Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.5.3 F Hoffmann-La Roche Antivirals Main Business and Markets Served

• 11.5.4 F Hoffmann-La Roche Antivirals Product Portfolio

• 11.5.5 Recent Research and Development Strategies

• 11.6 Cipla

• 11.6.1 Cipla Company Details

• 11.6.2 Cipla Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.6.3 Cipla Antivirals Main Business and Markets Served

• 11.6.4 Cipla Antivirals Product Portfolio

• 11.6.5 Recent Research and Development Strategies

• 11.7 Johnson & Johnson

• 11.7.1 Johnson & Johnson Company Details

• 11.7.2 Johnson & Johnson Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.7.3 Johnson & Johnson Antivirals Main Business and Markets Served

• 11.7.4 Johnson & Johnson Antivirals Product Portfolio

• 11.7.5 Recent Research and Development Strategies

• 11.8 Dr Reddy’s

• 11.8.1 Dr Reddy’s Company Details

• 11.8.2 Dr Reddy’s Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.8.3 Dr Reddy’s Antivirals Main Business and Markets Served

• 11.8.4 Dr Reddy’s Antivirals Product Portfolio

• 11.8.5 Recent Research and Development Strategies

• 11.9 Merck

• 11.9.1 Merck Company Details

• 11.9.2 Merck Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.9.3 Merck Antivirals Main Business and Markets Served

• 11.9.4 Merck Antivirals Product Portfolio

• 11.9.5 Recent Research and Development Strategies

• 11.10 Gilead Sciences

• 11.10.1 Gilead Sciences Company Details

• 11.10.2 Gilead Sciences Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.10.3 Gilead Sciences Antivirals Main Business and Markets Served

• 11.10.4 Gilead Sciences Antivirals Product Portfolio

• 11.10.5 Recent Research and Development Strategies

• 11.11 Teva Pharmaceutical Industries

• 11.11.1 Teva Pharmaceutical Industries Company Details

• 11.11.2 Teva Pharmaceutical Industries Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.11.3 Teva Pharmaceutical Industries Antivirals Main Business and Markets Served

• 11.11.4 Teva Pharmaceutical Industries Antivirals Product Portfolio

• 11.11.5 Recent Research and Development Strategies

• 11.12 Bristol-Myers-Squibb

• 11.12.1 Bristol-Myers-Squibb Company Details

• 11.12.2 Bristol-Myers-Squibb Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• 11.12.3 Bristol-Myers-Squibb Antivirals Main Business and Markets Served

• 11.12.4 Bristol-Myers-Squibb Antivirals Product Portfolio

• 11.12.5 Recent Research and Development Strategies

12 Global Antivirals Market Outlook by Types and Applications to 2028

• 12.1 Global Antivirals Consumption Forecast and Growth Rate by Type (2022-2028)

• 12.1.1 Global Generic Consumption Forecast and Growth Rate (2022-2028)

• 12.1.2 Global Branded Consumption Forecast and Growth Rate (2022-2028)

• 12.2 Global Antivirals Consumption Forecast and Growth Rate by Application (2022-2028)

• 12.2.1 Global Application I Consumption Forecast and Growth Rate (2022-2028)

• 12.2.2 Global HIV Consumption Forecast and Growth Rate (2022-2028)

• 12.2.3 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

• 12.2.4 Global HSV Consumption Forecast and Growth Rate (2022-2028)

• 12.2.5 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

13 Country-wise Antivirals Market Analysis and Outlook to 2028

• 13.1 Global Antivirals Consumption Forecast (2022-2028)

• 13.2 North America Consumption Analysis

• 13.2.1 United States Antivirals Consumption Forecast (2022-2028)

• 13.2.2 Canada Antivirals Consumption Forecast (2022-2028)

• 13.2.3 Mexico Antivirals Consumption Forecast (2022-2028)

• 13.3 Europe Consumption Analysis

• 13.3.1 Germany Antivirals Consumption Forecast (2022-2028)

• 13.3.2 UK Antivirals Consumption Forecast (2022-2028)

• 13.3.3 Spain Antivirals Consumption Forecast (2022-2028)

• 13.3.4 Belgium Antivirals Consumption Forecast (2022-2028)

• 13.3.5 France Antivirals Consumption Forecast (2022-2028)

• 13.3.6 Italy Antivirals Consumption Forecast (2022-2028)

• 13.3.7 Denmark Antivirals Consumption Forecast (2022-2028)

• 13.3.8 Finland Antivirals Consumption Forecast (2022-2028)

• 13.3.9 Norway Antivirals Consumption Forecast (2022-2028)

• 13.3.10 Sweden Antivirals Consumption Forecast (2022-2028)

• 13.3.11 Poland Antivirals Consumption Forecast (2022-2028)

• 13.3.12 Russia Antivirals Consumption Forecast (2022-2028)

• 13.3.13 Turkey Antivirals Consumption Forecast (2022-2028)

• 13.4 APAC Consumption Analysis

• 13.4.1 China Antivirals Consumption Forecast (2022-2028)

• 13.4.2 Japan Antivirals Consumption Forecast (2022-2028)

• 13.4.3 India Antivirals Consumption Forecast (2022-2028)

• 13.4.4 South Korea Antivirals Consumption Forecast (2022-2028)

• 13.4.5 Pakistan Antivirals Consumption Forecast (2022-2028)

• 13.4.6 Bangladesh Antivirals Consumption Forecast (2022-2028)

• 13.4.7 Indonesia Antivirals Consumption Forecast (2022-2028)

• 13.4.8 Thailand Antivirals Consumption Forecast (2022-2028)

• 13.4.9 Singapore Antivirals Consumption Forecast (2022-2028)

• 13.4.10 Malaysia Antivirals Consumption Forecast (2022-2028)

• 13.4.11 Philippines Antivirals Consumption Forecast (2022-2028)

• 13.4.12 Vietnam Antivirals Consumption Forecast (2022-2028)

• 13.5 South America Consumption Analysis

• 13.5.1 Brazil Antivirals Consumption Forecast (2022-2028)

• 13.5.2 Colombia Antivirals Consumption Forecast (2022-2028)

• 13.5.3 Chile Antivirals Consumption Forecast (2022-2028)

• 13.5.4 Argentina Antivirals Consumption Forecast (2022-2028)

• 13.5.5 Venezuela Antivirals Consumption Forecast (2022-2028)

• 13.5.6 Peru Antivirals Consumption Forecast (2022-2028)

• 13.5.7 Puerto Rico Antivirals Consumption Forecast (2022-2028)

• 13.5.8 Ecuador Antivirals Consumption Forecast (2022-2028)

• 13.6 GCC Consumption Analysis

• 13.6.1 Bahrain Antivirals Consumption Forecast (2022-2028)

• 13.6.2 Kuwait Antivirals Consumption Forecast (2022-2028)

• 13.6.3 Oman Antivirals Consumption Forecast (2022-2028)

• 13.6.4 Qatar Antivirals Consumption Forecast (2022-2028)

• 13.6.5 Saudi Arabia Antivirals Consumption Forecast (2022-2028)

• 13.6.6 United Arab Emirates Antivirals Consumption Forecast (2022-2028)

• 13.7 Africa Consumption Analysis

• 13.7.1 Nigeria Antivirals Consumption Forecast (2022-2028)

• 13.7.2 South Africa Antivirals Consumption Forecast (2022-2028)

• 13.7.3 Egypt Antivirals Consumption Forecast (2022-2028)

• 13.7.4 Algeria Antivirals Consumption Forecast (2022-2028)

• 13.8 Oceania Consumption Analysis

• 13.8.1 Australia Antivirals Consumption Forecast (2022-2028)

• 13.8.2 New Zealand Antivirals Consumption Forecast (2022-2028)

14 Conclusions

The List of Tables and Figures

• Table Definition of Antivirals

• Figure of Antivirals Picture

• Table Global Antivirals Import by Region (Top 10 Countries) (2017-2028)

• Table Global Antivirals Export by Region (Top 10 Countries) (2017-2028)

• Figure Global Generic Consumption and Growth Rate (2017-2022)

• Figure Global Branded Consumption and Growth Rate (2017-2022)

• Figure Global Application I Consumption and Growth Rate (2017-2022)

• Figure Global HIV Consumption and Growth Rate (2017-2022)

• Figure Global Hepatitis Consumption and Growth Rate (2017-2022)

• Figure Global HSV Consumption and Growth Rate (2017-2022)

• Figure Global Influenza Consumption and Growth Rate (2017-2022)

• Figure Global Antivirals Consumption by Country (2017-2022)

• Table North America Antivirals Consumption by Country (2017-2022)

• Figure United States Antivirals Consumption and Growth Rate (2017-2022)

• Figure Canada Antivirals Consumption and Growth Rate (2017-2022)

• Figure Mexico Antivirals Consumption and Growth Rate (2017-2022)

• Table Europe Antivirals Consumption by Country (2017-2022)

• Figure Germany Antivirals Consumption and Growth Rate (2017-2022)

• Figure UK Antivirals Consumption and Growth Rate (2017-2022)

• Figure Spain Antivirals Consumption and Growth Rate (2017-2022)

• Figure Belgium Antivirals Consumption and Growth Rate (2017-2022)

• Figure France Antivirals Consumption and Growth Rate (2017-2022)

• Figure Italy Antivirals Consumption and Growth Rate (2017-2022)

• Figure Denmark Antivirals Consumption and Growth Rate (2017-2022)

• Figure Finland Antivirals Consumption and Growth Rate (2017-2022)

• Figure Norway Antivirals Consumption and Growth Rate (2017-2022)

• Figure Sweden Antivirals Consumption and Growth Rate (2017-2022)

• Figure Poland Antivirals Consumption and Growth Rate (2017-2022)

• Figure Russia Antivirals Consumption and Growth Rate (2017-2022)

• Figure Turkey Antivirals Consumption and Growth Rate (2017-2022)

• Table APAC Antivirals Consumption by Country (2017-2022)

• Figure China Antivirals Consumption and Growth Rate (2017-2022)

• Figure Japan Antivirals Consumption and Growth Rate (2017-2022)

• Figure India Antivirals Consumption and Growth Rate (2017-2022)

• Figure South Korea Antivirals Consumption and Growth Rate (2017-2022)

• Figure Pakistan Antivirals Consumption and Growth Rate (2017-2022)

• Figure Bangladesh Antivirals Consumption and Growth Rate (2017-2022)

• Figure Indonesia Antivirals Consumption and Growth Rate (2017-2022)

• Figure Thailand Antivirals Consumption and Growth Rate (2017-2022)

• Figure Singapore Antivirals Consumption and Growth Rate (2017-2022)

• Figure Malaysia Antivirals Consumption and Growth Rate (2017-2022)

• Figure Philippines Antivirals Consumption and Growth Rate (2017-2022)

• Figure Vietnam Antivirals Consumption and Growth Rate (2017-2022)

• Table South America Antivirals Consumption by Country (2017-2022)

• Figure Brazil Antivirals Consumption and Growth Rate (2017-2022)

• Figure Colombia Antivirals Consumption and Growth Rate (2017-2022)

• Figure Chile Antivirals Consumption and Growth Rate (2017-2022)

• Figure Argentina Antivirals Consumption and Growth Rate (2017-2022)

• Figure Venezuela Antivirals Consumption and Growth Rate (2017-2022)

• Figure Peru Antivirals Consumption and Growth Rate (2017-2022)

• Figure Puerto Rico Antivirals Consumption and Growth Rate (2017-2022)

• Figure Ecuador Antivirals Consumption and Growth Rate (2017-2022)

• Table GCC Antivirals Consumption by Country (2017-2022)

• Figure Bahrain Antivirals Consumption and Growth Rate (2017-2022)

• Figure Kuwait Antivirals Consumption and Growth Rate (2017-2022)

• Figure Oman Antivirals Consumption and Growth Rate (2017-2022)

• Figure Qatar Antivirals Consumption and Growth Rate (2017-2022)

• Figure Saudi Arabia Antivirals Consumption and Growth Rate (2017-2022)

• Figure United Arab Emirates Antivirals Consumption and Growth Rate (2017-2022)

• Table Africa Antivirals Consumption by Country (2017-2022)

• Figure Nigeria Antivirals Consumption and Growth Rate (2017-2022)

• Figure South Africa Antivirals Consumption and Growth Rate (2017-2022)

• Figure Egypt Antivirals Consumption and Growth Rate (2017-2022)

• Figure Algeria Antivirals Consumption and Growth Rate (2017-2022)

• Table Oceania Antivirals Consumption by Country (2017-2022)

• Figure Australia Antivirals Consumption and Growth Rate (2017-2022)

• Figure New Zealand Antivirals Consumption and Growth Rate (2017-2022)

• Table GSK Company Details

• Table GSK Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table GSK Antivirals Main Business and Markets Served

• Table GSK Antivirals Product Portfolio

• Table Aurobindo Pharma Company Details

• Table Aurobindo Pharma Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Aurobindo Pharma Antivirals Main Business and Markets Served

• Table Aurobindo Pharma Antivirals Product Portfolio

• Table Mylan Company Details

• Table Mylan Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Mylan Antivirals Main Business and Markets Served

• Table Mylan Antivirals Product Portfolio

• Table AbbVie Company Details

• Table AbbVie Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table AbbVie Antivirals Main Business and Markets Served

• Table AbbVie Antivirals Product Portfolio

• Table F Hoffmann-La Roche Company Details

• Table F Hoffmann-La Roche Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table F Hoffmann-La Roche Antivirals Main Business and Markets Served

• Table F Hoffmann-La Roche Antivirals Product Portfolio

• Table Cipla Company Details

• Table Cipla Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Cipla Antivirals Main Business and Markets Served

• Table Cipla Antivirals Product Portfolio

• Table Johnson & Johnson Company Details

• Table Johnson & Johnson Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Johnson & Johnson Antivirals Main Business and Markets Served

• Table Johnson & Johnson Antivirals Product Portfolio

• Table Dr Reddy’s Company Details

• Table Dr Reddy’s Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Dr Reddy’s Antivirals Main Business and Markets Served

• Table Dr Reddy’s Antivirals Product Portfolio

• Table Merck Company Details

• Table Merck Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Merck Antivirals Main Business and Markets Served

• Table Merck Antivirals Product Portfolio

• Table Gilead Sciences Company Details

• Table Gilead Sciences Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Gilead Sciences Antivirals Main Business and Markets Served

• Table Gilead Sciences Antivirals Product Portfolio

• Table Teva Pharmaceutical Industries Company Details

• Table Teva Pharmaceutical Industries Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Teva Pharmaceutical Industries Antivirals Main Business and Markets Served

• Table Teva Pharmaceutical Industries Antivirals Product Portfolio

• Table Bristol-Myers-Squibb Company Details

• Table Bristol-Myers-Squibb Antivirals Sales, Price, Value and Gross Profit (2017-2022)

• Table Bristol-Myers-Squibb Antivirals Main Business and Markets Served

• Table Bristol-Myers-Squibb Antivirals Product Portfolio

• Figure Global Generic Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Branded Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Application I Consumption Forecast and Growth Rate (2022-2028)

• Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)

• Figure Global HSV Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

• Figure Global Antivirals Consumption Forecast by Country (2022-2028)

• Table North America Antivirals Consumption Forecast by Country (2022-2028)

• Figure United States Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Canada Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Mexico Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table Europe Antivirals Consumption Forecast by Country (2022-2028)

• Figure Germany Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure UK Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Spain Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Belgium Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure France Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Italy Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Denmark Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Finland Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Norway Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Sweden Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Poland Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Russia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Turkey Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table APAC Antivirals Consumption Forecast by Country (2022-2028)

• Figure China Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Japan Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure India Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure South Korea Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Pakistan Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Bangladesh Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Indonesia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Thailand Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Singapore Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Malaysia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Philippines Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Vietnam Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table South America Antivirals Consumption Forecast by Country (2022-2028)

• Figure Brazil Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Colombia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Chile Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Argentina Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Venezuela Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Peru Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Puerto Rico Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Ecuador Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table GCC Antivirals Consumption Forecast by Country (2022-2028)

• Figure Bahrain Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Kuwait Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Oman Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Qatar Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Saudi Arabia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure United Arab Emirates Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table Africa Antivirals Consumption Forecast by Country (2022-2028)

• Figure Nigeria Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure South Africa Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Egypt Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure Algeria Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Table Oceania Antivirals Consumption Forecast by Country (2022-2028)

• Figure Australia Antivirals Consumption Forecast and Growth Rate (2022-2028)

• Figure New Zealand Antivirals Consumption Forecast and Growth Rate (2022-2028)